Advertisement

Topics

Future At Stake, Zafgen Gives First Glimpse of New Obesity Drug Data

16:00 EDT 4 May 2017 | Xconomy

Zafgen took a big hit last year when two patient deaths forced it to abandon its most advanced drug, belaronib. The company is now looking to a new experimental weight loss drug for diabetics to turn its fortunes around, with the first glimpse at early data released this afternoon. Many caveats apply. The data are […]

Original Article: Future At Stake, Zafgen Gives First Glimpse of New Obesity Drug Data

NEXT ARTICLE

More From BioPortfolio on "Future At Stake, Zafgen Gives First Glimpse of New Obesity Drug Data"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...